Page last updated: 2024-10-22

acetazolamide and B16 Melanoma

acetazolamide has been researched along with B16 Melanoma in 1 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, ZC1
Qin, YJ1
Wang, PF1
Yang, YA1
Wen, Q1
Zhang, X1
Qiu, HY1
Duan, YT1
Wang, YT1
Sang, YL1
Zhu, HL1

Other Studies

1 other study available for acetazolamide and B16 Melanoma

ArticleYear
Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis.
    European journal of medicinal chemistry, 2013, Volume: 66

    Topics: Antineoplastic Agents; Apoptosis; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anh

2013